Published in Gene Therapy Weekly, August 29th, 2002
"To evaluate the function of endogenous NK4 and investigate its potential inhibitory effect, TMK1 cells were transfected with NK4 plasmid," S. Hirao and colleagues, Nara Medical University, Japan, described in a recent report.
Upon identifying those cells that expressed NK4, Hirao and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.